Form D · Other Technology
INOVISE MEDICAL INC
Beaverton, OR · CIK 0001120221
Offering snapshot reported Sep 6, 2012 · SEC filing
- Reported sold
- $450K Offering amount: $4.2M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 31, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2012 | Initial | $449,512 | No comparison | 5 | SEC filing |
| Feb 16, 2011 | Initial | $4,409,721 | No comparison | 3 | SEC filing |
| Jul 9, 2009 | Initial | $920,000 | No comparison | 1 | SEC filing |
| Nov 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 11, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-183703
Source: Form D, filed Sep 6, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Bauer | Director, Executive |
| David Chazanovitz | Director |
| Dallas Ross | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
8770 Sw Nimbus Avenue Suite D
Beaverton, OR, 97008
Beaverton, OR, 97008